Skip to main content

Advertisement

Table 1 Demographic and clinical characteristics of patients with Hurthle cell carcinoma

From: Survival and prognostic factors for survival, cancer specific survival and disease free interval in 239 patients with Hurthle cell carcinoma: a single center experience

Variable Number Percent
Gender
 Female 187 78.2
 Males 52 21,8
Age 54,3 ± 13,7  
 20–29 10 4,2
 30–39 28 11,7
 40–49 46 19,2
 50–59 66 27,6
 60–69 53 22,2
  > 70 36 15,1
pT tumor stage
 T1 19 7,9
 T2 112 46,9
 T3 75 31,4
 T4 33 13,8
N stage
 N0 72 30,1
 N1a 5 2,1
 N1b 1 0,4
 Nx 161 67,4
Tumor invasiveness
 minimally invasive 102 67,1
 widely invasive 50 32,9
Tumor size (mm)
  <39 93 46
  ≥40 109 54
Capsular invasion
 transcapsular 152 69,7
 no or minimal 66 30,3
Vascular invasion
 positive 146 67
 no or minimal 72 33
Number of tumor focuses
 one focus 167 76,6
 multicentric 51 21,3
Regional tumor infiltration
 positive 33 13,8
 negative 206 86,2
Thyroglobulin
 normal values (<68 ng/mL) 19 26,8
 elevated values (>68 ng/mL) 52 73,2
Radioiodine ablation after surgery
 Yes 65 36,9
 No 111 63,1
Surgeon experience
 resident 11 4,6
 specialist 1–5 years 20 8,4
 specialist 6–10 years 57 23,8
 specialist over 10 years 151 63,2